Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Topical tacalcitol ointment can help improve symptoms of EFFC.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

QMSI is a valuable method for studying drug penetration in skin tissues.

Quzhi Fangtuo Pill is more effective than Chuzhi Shengfa Pill for early hair loss.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Yiqi Huayu medicine can effectively reduce BPH in rats by lowering MMP-2 levels and blood vessel growth.

QIA-64 software can measure straight wire lengths accurately but needs improvement for curved wires and width measurements.

Isoquercitrin helps hair grow by activating certain cell processes.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Compound Baqia Danshen Liniment may effectively treat vitiligo by improving skin and hair pigmentation and reducing inflammation.

A new compound was effective for imaging prostate cancer in rats.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

CTP-543 is generally safe for treating alopecia areata.

Different ligands change the shape of the TRPV3 ion channel in unique ways.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

MitoQ may help treat hair loss by boosting hair growth pathways.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Tofacitinib may help treat severe hair loss, but more research is needed.